Royal Philips (NYSE:PHG) said yesterday it launched the DreamStation Go positive airway pressure device designed for individuals with obstructive sleep apnea.
The Amsterdam-based company touted the devices as its smallest to date at half the size of previous generation devices, designed to be easy to travel with. The device weighs less than 2 pounds, features a built in power supply and meets FAA standards for in-flight use.
“Traveling with a sleep therapy device can be a cumbersome experience for patients with obstructive sleep apnea. While we have made strides to reduce the size and weight of our machines in recent years, most are still carried as a separate piece of luggage—a fact that has led many users to resent and even forego therapy during travel. We designed the DreamStation Go as a holistic system with compact features and proven performance to help eliminate the need to sacrifice reliable therapy for convenience when traveling and vice versa – allowing for the best possible night’s sleep no matter where it happens,” OSA patient and sleep therapy biz leader Mark D’Angelo said in a prepared statement.
Philips said the device is currently available for direct purchase in the US, with an expansion into global markets during the summer.
In March, Philips Respironics business announced a select recall of its V60 respiratory ventilators with its version 2.20 software over issues with the software causing the blower motor to stall and the unit to shut down, according to a recall notice released this week.